RxDoctor Payments Data

Jennifer Warren

Psychiatric/Mental Health · Tupelo, MSNPI 1356707400

Payments from drug & device makers

$2,436in general payments, 2019–2025

Across 153 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$534
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$356
  • Johnson & Johnson$283
  • Otsuka America Pharmaceutical, Inc.$228
  • Axsome Therapeutics, Inc.$218
  • Novo Nordisk$155
  • plus $661 from 15 others

What the payments were for

  • Food & beverage$2,436100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,436 in reported general payments places this provider in the 75th percentile of 486 psychiatric/mental health providers in Mississippi.

See all psychiatric/mental health providers in Mississippi

Medicare billing

Part B allowed, 2024
$14,276
Medicare patients
34
Services billed
197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CaplytaLumateperone Tosylate26$43,014
Abilify MaintenaAripiprazole11$30,700
Clomipramine Hcl16$3,254
Aripiprazole23$1,936
Duloxetine Hcl43$802
Bupropion Hcl SrBupropion Hcl43$661
Buspirone Hcl49$536
Methylphenidate Hcl13$535
Naltrexone Hcl11$337
Lamotrigine31$293
Trazodone Hcl32$282
Venlafaxine Hcl ErVenlafaxine Hcl15$262
Clonazepam33$214
Divalproex Sodium20$213
Hydroxyzine Pamoate13$205

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$356$43,01426 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$228$30,70011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 486 psychiatric/mental health providers in Mississippi.

Other psychiatric/mental health in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →